Marquette Asset Management, LLC Zoetis Inc. Transaction History

Marquette Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	SELL	$151.44 - $200.09 $2,423 - $3,201	-16 Reduced 13.91%	99 $19,000
Q3 2023 Oct 27, 2023	SELL	$167.14 - $192.77 $3,677 - $4,240	-22 Reduced 16.06%	115 $20,000
Q2 2023 Jul 28, 2023	BUY	$160.94 - $186.23 $22,048 - $25,513	137 New	137 $23,000
Q3 2022 Oct 06, 2022	SELL	$148.29 - $182.55 $593 - $730	-4 Reduced 2.23%	175 $25,000
Q1 2022 Apr 26, 2022	BUY	$181.39 - $234.03 $725 - $936	4 Added 2.29%	179 $34,000
Q4 2019 Jan 28, 2020	SELL	$116.25 - $133.25 $20,343 - $23,318	-175 Reduced 50.0%	175 $23,000
Q3 2019 Oct 22, 2019	BUY	$112.57 - $128.43 $39,399 - $44,950	350 New	350 $44,000

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Marquette Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Marquette Asset Management, LLC with notifications on news.